Predictive Value of Platelet-to-albumin Ratio Combined with the CHEST Score for New-Onset Atrial Fibrillation in Elderly Patients with Acute ST-segment Elevation Myocardial Infarction

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2024 Sep 28

PMID 39333846

Authors

Fangyuan Wang

Yudan Sun

Yuan Lu

Defeng Pan

Ni An

Rongrong Liu

Shengli Li

Tian Liu

Rongli Yang

Affiliations

Soon will be listed here.

Abstract

Background: New-onset atrial fibrillation (NOAF) is a common adverse outcome in acute ST-segment elevation myocardial infarction (STEMI) patients following percutaneous coronary intervention (PCI) and is associated with a worse prognosis. The platelet-to-albumin ratio (PAR) has been utilized to predict the severity and prognosis of cardiovascular diseases. This study aims to investigate the predictive value of PAR combined with the CHEST score for NOAF in the elderly population with STEMI undergoing PCI.

Methods: 445 elderly STEMI patients without a history of atrial fibrillation (AF) who underwent PCI were consecutively enrolled in this study. Multivariate logistic regression analysis was used to identify independent risk factors for NOAF after PCI.

Results: 50 patients (11.2%) developed NOAF after PCI. Multivariate logistic regression analysis revealed that heart rate (HR), systemic immune-inflammation index (SII), uric acid (UA), PAR, and CHEST score were independent risk factors for NOAF. The area under the curve (AUC) of the combined PAR and CHEST score was 0.839, and Delong's test indicated that the combined model had superior predictive value compared to individual markers (AUC of PAR: 0.738; AUC of CHEST score: 0.752) (P < 0.05). The addition of PAR and CHEST score to this model (HR, SII, and UA) significantly improved the reclassification and discrimination ability (IDI 0.175; NRI 0.734, both P < 0.001). During regular follow-up, the incidence of MACE was higher in the NOAF group compared to the non-NOAF group.

Conclusion: The combination of PAR and the CHEST score has a high predictive value for NOAF in elderly STEMI patients following PCI.

Citing Articles

The monocyte-to-HDL-cholesterol ratio predicts new-onset atrial fibrillation in patients with acute STEMI.

Tanik V, Tunca C, Kalkan K, Kivrak A, Ozlek B Biomark Med. 2025; 19(4):121-128.

PMID: 39878450 PMC: 11834425. DOI: 10.1080/17520363.2025.2459590.

Correlation between triglyceride-glucose index and atrial fibrillation in acute coronary syndrome patients: a retrospective cohort study and the establishment of a LASSO-Logistic regression model.

Yao C, Qin Y, Yan X, Zhao Z, Wang B, Bai Y BMC Cardiovasc Disord. 2024; 24(1):702.

PMID: 39639225 PMC: 11619280. DOI: 10.1186/s12872-024-04385-x.

References

Medina-Leyte D, Zepeda-Garcia O, Dominguez-Perez M, Gonzalez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L . Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int J Mol Sci. 2021; 22(8). PMC: 8068178. DOI: 10.3390/ijms22083850. View

Biccire F, Tanzilli G, Prati F, Sammartini E, Gelfusa M, Celeski M . Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry. Int J Cardiol. 2023; 386:45-49. DOI: 10.1016/j.ijcard.2023.05.023. View

Holinstat M . Normal platelet function. Cancer Metastasis Rev. 2017; 36(2):195-198. PMC: 5709181. DOI: 10.1007/s10555-017-9677-x. View

Karakayali M, Altunova M, Yakisan T, Aslan S, Omar T, Artac I . The Relationship between the Systemic Immune-Inflammation Index and Ischemia with Non-Obstructive Coronary Arteries in Patients Undergoing Coronary Angiography. Arq Bras Cardiol. 2024; 121(2):e20230540. DOI: 10.36660/abc.20230540. View

Li W, Song Y . Red cell distribution width to albumin ratio is a risk factor for atrial fibrillation in subjects hospitalized with coronary angiography. BMC Cardiovasc Disord. 2024; 24(1):95. PMC: 10854169. DOI: 10.1186/s12872-024-03772-8. View

Mazzone A, Scalese M, Paradossi U, Del Turco S, Botto N, De Caterina A . Development and validation of a risk stratification score for new-onset atrial fibrillation in STEMI patients undergoing primary percutaneous coronary intervention. Int J Clin Pract. 2018; 72(4):e13087. DOI: 10.1111/ijcp.13087. View

Don B, Kaysen G . Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2005; 17(6):432-7. DOI: 10.1111/j.0894-0959.2004.17603.x. View

Rencuzogullari I, Cagdas M, Karakoyun S, Yesin M, Gursoy M, Artac I . Propensity score matching analysis of the impact of Syntax score and Syntax score II on new onset atrial fibrillation development in patients with ST segment elevation myocardial infarction. Ann Noninvasive Electrocardiol. 2017; 23(2):e12504. PMC: 6931703. DOI: 10.1111/anec.12504. View

Hansson G . Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352(16):1685-95. DOI: 10.1056/NEJMra043430. View

10.

Sagris M, Vardas E, Theofilis P, Antonopoulos A, Oikonomou E, Tousoulis D . Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. Int J Mol Sci. 2022; 23(1). PMC: 8744894. DOI: 10.3390/ijms23010006. View

11.

Li Y, Pastori D, Miyazawa K, Shahid F, Lip G . Identifying At-Risk Patients for Sustained Atrial High-Rate Episodes Using the CHEST Score: The West Birmingham Atrial Fibrillation Project. J Am Heart Assoc. 2021; 10(6):e017519. PMC: 8174218. DOI: 10.1161/JAHA.120.017519. View

12.

Hu Y, Chen Y, Lin Y, Chen S . Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015; 12(4):230-43. DOI: 10.1038/nrcardio.2015.2. View

13.

Wrigley B, Lip G, Shantsila E . The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail. 2011; 13(11):1161-71. DOI: 10.1093/eurjhf/hfr122. View

14.

Hao P, Feng S, Suo M, Wang S, Wu X . Platelet to albumin ratio: A risk factor related to prognosis in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. Int J Cardiol. 2023; 395:131588. DOI: 10.1016/j.ijcard.2023.131588. View

15.

Li Y, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B . C HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study. J Am Heart Assoc. 2019; 8(13):e012546. PMC: 6662366. DOI: 10.1161/JAHA.119.012546. View

16.

Clark D, Plumb V, EPSTEIN A, Kay G . Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997; 30(4):1039-45. DOI: 10.1016/s0735-1097(97)00254-4. View

17.

Libby P . Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(9):2045-51. PMC: 3422754. DOI: 10.1161/ATVBAHA.108.179705. View

18.

Crea F, Libby P . Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment. Circulation. 2017; 136(12):1155-1166. PMC: 5679086. DOI: 10.1161/CIRCULATIONAHA.117.029870. View

19.

Arques S . Serum albumin and cardiovascular disease: State-of-the-art review. Ann Cardiol Angeiol (Paris). 2020; 69(4):192-200. DOI: 10.1016/j.ancard.2020.07.012. View

20.

Tan J, Song G, Wang S, Dong L, Liu X, Jiang Z . Platelet-to-Albumin Ratio: A Novel IgA Nephropathy Prognosis Predictor. Front Immunol. 2022; 13:842362. PMC: 9162245. DOI: 10.3389/fimmu.2022.842362. View